Jonathan P. Piccini

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.3K citations · Full text

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

José A. Joglar, Mina K. Chung, Anastasia L. Armbruster et al. · Circulation · 2023 · 2K citations · Full text

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

Douglas L. Packer, Daniel B. Mark, Richard A. Robb et al. · JAMA · 2019 · 1.4K citations · Full text

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation

José A. Joglar, Mina K. Chung, Anastasia L. Armbruster et al. · Journal of the American College of Cardiology · 2023 · 606 citations · Full text

Electrophysiological Evaluation, Acc/aha/accp/hrs Guideline, Cardiovascular Disease +6

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

Keith A.A. Fox, Jonathan P. Piccini, Daniel Wojdyla et al. · European Heart Journal · 2011 · 603 citations